Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.

Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS. 

In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.

Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations.

Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.

In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis.

In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS.

Description: Dr. Anthony Feinstein of the University of Toronto and Sunnybrook Health Sciences Center in Ontario, Canada and author of the recently released book Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis, shares his expert knowledge and research about cognitive dysfunction in MS and how we are learning to treat this troublesome problem. 

In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 2 provides tools for managing the fatigue that troubles many individuals with MS.

In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS.  This first episode discusses tools for managing the heat sensitivity and exercise intolerance experienced by many with MS. 

Dr. Edith Graham of Northwestern University summarizes the current state of knowledge on the use of disease-modifying treatments in women who wish to become or are pregnant including IVF treatment and the postpartum period.